ClinVar Miner

Submissions for variant NM_001370658.1(BTD):c.1395C>G (p.His465Gln) (rs201604102)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Research and Development, ARUP Laboratories RCV000022015 SCV000042687 pathogenic Biotinidase deficiency 2017-02-17 criteria provided, single submitter clinical testing Enzyme activity @ 0.7 U/L. Seen with a complex mutation [c.1330G>C,c.511G>A; p.D444H,p.A171T]
Counsyl RCV000022015 SCV000800642 uncertain significance Biotinidase deficiency 2017-12-28 criteria provided, single submitter clinical testing
Invitae RCV000022015 SCV000832890 likely pathogenic Biotinidase deficiency 2018-05-25 criteria provided, single submitter clinical testing This sequence change replaces histidine with glutamine at codon 485 of the BTD protein (p.His485Gln). The histidine residue is moderately conserved and there is a small physicochemical difference between histidine and glutamine. This variant is present in population databases (rs201604102, ExAC 0.02%). This variant has been observed as homozygous or in combination with a BTD pathogenic variant in individuals affected with profound biotinidase deficiency (PMID: 25967232, 26810761). ClinVar contains an entry for this variant (Variation ID: 25090). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Mendelics RCV000022015 SCV001136349 pathogenic Biotinidase deficiency 2019-05-28 criteria provided, single submitter clinical testing
Natera, Inc. RCV000022015 SCV001461227 likely pathogenic Biotinidase deficiency 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.